|
1
|
Kerachian MA, Séguin C and Harvey EJ:
Glucocorticoids in osteonecrosis of the femoral head: a new
understanding of the mechanisms of action. J Steroid Biochem Mol
Biol. 114:121–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miska EA, Alvarez-Saavedra E, Townsend M,
et al: Microarray analysis of microRNA expression in the developing
mammalian brain. Genome Biol. 5:R682004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bloomston M, Frankel WL, Petrocca F, et
al: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar
|
|
5
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schetter AJ, Leung SY, Sohn JJ, et al:
MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanemaru H, Fukushima S, Yamashita J, et
al: The circulating microRNA-221 level in patients with malignant
melanoma as a new tumor marker. J Dermatol Sci. 61:187–193. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Asaga S, Kuo C, Nguyen T, Terpenning M,
Giuliano AE and Hoon DS: Direct serum assay for microRNA-21
concentrations in early and advanced breast cancer. Clin Chem.
57:84–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boeri M, Verri C, Conte D, et al: MicroRNA
signatures in tissues and plasma predict development and prognosis
of computed tomography detected lung cancer. Proc Natl Acad Sci
USA. 108:3713–3718. 2011. View Article : Google Scholar
|
|
10
|
Wang GK, Zhu JQ, Zhang JT, et al:
Circulating microRNA: a novel potential biomarker for early
diagnosis of acute myocardial infarction in humans. Eur Heart J.
31:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tijsen AJ, Creemers EE, Moerland PD, et
al: MiR423-5p as a circulating biomarker for heart failure. Circ
Res. 106:1035–1039. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fichtlscherer S, De Rosa S, Fox H, et al:
Circulating microRNAs in patients with coronary artery disease.
Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kozomara A and Griffiths-Jones S: miRBase:
annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lawrie CH, Gal S, Dunlop HM, et al:
Detection of elevated levels of tumor-associated microRNAs in serum
of patients with diffuse large B cell lymphoma. Br J Haematol.
141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Syring I, Bartels J, Holdenrieder S, et
al: Circulating serum microRNA (miR-367-3p, miR-371a-3p,
miR-372-3p, miR-373-3p) as biomarkers for patients with testicular
germ cell cancers. J Urol. Jul 18–2014.(Epub ahead of print).
|
|
17
|
Slater EP, Strauch K, Rospleszcz S, et al:
MicroRNA-196a and -196b as potential biomarkers for the early
detection of familial pancreatic cancer. Transl Oncol. 7:464–471.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sochor M, Basova P, Pesta M, et al:
Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable
monitoring of early breast cancer in serum. BMC Cancer. 14:4482014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Resnick KE, Alder H, Hagan JP, et al: The
detection of differentially expressed microRNAs from the serum of
ovarian cancer patients using a novel real-time PCR platform.
Gynecol Oncol. 112:55–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sukata T, Sumida K, Kushida M, et al:
Circulating microRNAs, possible indicators of progress of rat
hepatocarcinogenesis from early stages. Toxicol Lett. 200:46–52.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun
S, et al: miR-15b and miR-16 modulate multidrug resistance by
targeting BCL2 in human gastric cancer cells. Int J Cancer.
123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hullinger TG, Montgomery RL, Seto AG,
Dickinson BA, Semus HM, Lynch JM, et al: Inhibition of miR-15
protects against cardiac ischemic injury. Circ Res. 110:71–81.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu L, Chen L, Xu Y, Li R and Du X:
microRNA-195 promotes apoptosis and suppresses tumorigenicity of
human colorectal cancer cells. Biochem Biophys Res Commun.
400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meseguer S, Mudduluru G, Escamilla JM,
Allgayer H and Barettino D: Micro-RNAs-10a and-10b contribute to
retinoic acid-induced differentiation of neuroblastoma cells and
target the alternative splicing regulatory factor SFRS1 (SF2/ASF).
J Biol Chem. 286:4150–4164. 2011. View Article : Google Scholar
|
|
25
|
Huang H, Xie C, Sun X, Ritchie RP, Zhang J
and Chen YE: miR-10a contributes to retinoid acid-induced smooth
muscle cell differentiation. J Biol Chem. 285:9383–9389. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim N, Kim H, Jung I, Kim Y, Kim D and Han
YM: Expression profiles of microRNAs in human embryonic stem cells
during hepatocyte differentiation. Hepatol Res. 41:170–183. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ho J, Pandey P, Schatton T, Sims-Lucas S,
Khalid M, Frank MH, et al: The pro-apoptotic protein Bim is a
microRNA target in kidney progenitors. J Am Soc Nephrol.
22:1053–1063. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohuchida K, Mizumoto K, Lin C, Yamaguchi
H, Ohtsuka T, Sato N, et al: MicroRNA-10a is overexpressed in human
pancreatic cancer and involved in its invasiveness partially via
suppression of the HOXA1 gene. Ann Surg Oncol. 19:2394–2402. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen X, Fang J, Lv X, Pei Z, Wang Y, Jiang
S and Ding K: Heparin impairs angiogenesis through inhibition of
microRNA-10b. J Biol Chem. 286:26616–26627. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gabriely G, Yi M, Narayan RS, Niers JM,
Wurdinger T, Imitola J, et al: Human glioma growth is controlled by
microRNA-10b. Cancer Res. 71:3563–3572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rosa A, Papaioannou MD, Krzyspiak JE and
Brivanlou AH: miR-373 is regulated by TGFβ signaling and promotes
mesendoderm differentiation in human Embryonic Stem Cells. Dev
Biol. 391:81–88. 2014.PubMed/NCBI
|
|
32
|
Alliston T, Choi L, Ducy P, et al:
TGF-beta induced repression of CBFA1 by Smad3 decreases cbfal and
osteocalcin expression and inhibits osteoblast differentiation (J).
EMBO J. 20:2254–2272. 2001. View Article : Google Scholar
|
|
33
|
Ducy P, Zhang R, Geoffroy V, Ridall AL and
Karsenty G: Osf2/Cbfa1: a transcriptional activator of osteoblast
differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato
M, Okamoto R, Kitamura Y, Yoshiki S and Kishimoto T: Targeted
disruption of Cbfa1 results in a complete lack of bone formation
owing to maturational arrest of osteoblasts. Cell. 89:755–764.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Otto F, Thornell AP, Crompton T, Denzel A,
Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen
BR, Selby PB and Owen MJ: Cbfa1, a candidate gene for cleidocranial
dysplasia syndrome, is essential for osteoblast differentiation and
bone development. Cell. 89:765–771. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ducy P, Starbuck M, Priemel M, Shen J,
Pinero G, Geoffroy V, Amling M and Karsenty G: A Cbfa1-dependent
genetic pathway controls bone formation beyond embryonic
development. Genes Dev. 13:1025–1036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hjelmeland AB, Schilling SH, Guo X, et al:
Loss of Smad3 mediated negative regulation of Runx2 activity leads
to an alteration in cell fate determination. Mol Cell Biol.
25:9460–9468. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pais H, Nicolas FE, Soond SM, Swingler TE,
Clark IM, Chantry A, et al: Analyzing mRNA expression identifies
Smad3 as a microRNA-140 target regulated only at protein level.
RNA. 16:489–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY,
et al: A Runx2/miR-3960/miR-2861 regulatory feedback loop during
mouse osteoblast differentiation. J Biol Chem. 286:12328–12339.
2011. View Article : Google Scholar : PubMed/NCBI
|
